Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany

Kulp W, Hemels M, Greiner W, Graf VDJ (2005)
In: VALUE IN HEALTH. 8. BLACKWELL PUBLISHING: A210-A210.

Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Kulp W, Hemels M, Greiner W, Graf VDJ. Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. In: VALUE IN HEALTH. Vol 8. BLACKWELL PUBLISHING; 2005: A210-A210.
Kulp, W., Hemels, M., Greiner, W., & Graf, V. D. J. (2005). Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. VALUE IN HEALTH, 8(6), A210-A210.
Kulp, W., Hemels, M., Greiner, W., and Graf, V. D. J. (2005). “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany” in VALUE IN HEALTH, vol. 8, (BLACKWELL PUBLISHING), A210-A210.
Kulp, W., et al., 2005. Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. In VALUE IN HEALTH. no.8 BLACKWELL PUBLISHING, pp. A210-A210.
W. Kulp, et al., “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”, VALUE IN HEALTH, vol. 8, BLACKWELL PUBLISHING, 2005, pp.A210-A210.
Kulp, W., Hemels, M., Greiner, W., Graf, V.D.J.: Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany. VALUE IN HEALTH. 8, p. A210-A210. BLACKWELL PUBLISHING (2005).
Kulp, W, Hemels, M, Greiner, Wolfgang, and Graf, VDJ. “Cost-effectiveness analysis of escitalopram in the treatment of Major Depressive Disorder in Germany”. VALUE IN HEALTH. BLACKWELL PUBLISHING, 2005.Vol. 8. A210-A210.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar